Ingredion Incorporated reported Q1 2026 results with adjusted EPS of $2.34, down from $2.97 in Q1 2025, due to operational challenges at Argo facility, and adjusted full-year 2026 EPS guidance to $10.45-$11.15.
Key takeaways
Q1 2026 reported EPS $2.22 vs $3.00 in Q1 2025; adjusted EPS $2.34 vs $2.97.
Net sales $1,792 million, down 1% from $1,813 million in Q1 2025.
Reported operating income $203 million, down 26%; adjusted $212 million, down 22%.
F&II-U.S./CAN operating income fell 63% to $34 million due to Argo facility issues.
Updated FY2026 adjusted EPS guidance $10.45-$11.15; net sales flat to up low single-digits.
Q2 2026 adjusted operating income expected down high single-digits vs prior year.